“Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes.”

A second-year student in the MBSB graduate program, Anna Belford, in Professor James Conway’s lab already contributed to an exciting paper of SARS-CoV-2 variants. Two faculty members, Professors James Conway (Structural Biology) and Cheng Zhang (Pharmacology), in the MBSB program participated in this project led by Professor Yi Shi in the Department of Cell Biology, University of Pittsburgh School of Medicine.

 The paper was published in Nature Communications.